Novo Nordisk A/S (NVO)
46.36
-0.41
(-0.88%)
USD |
NYSE |
Dec 09, 16:00
47.06
+0.70
(+1.51%)
Pre-Market: 07:17
Novo Nordisk Total Liabilities (Quarterly): 53.90B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Evaxion AS | 14.90M |
| Ascendis Pharma A/S | 1.561B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Omeros Corp. | 406.18M |
| Viking Therapeutics, Inc. | 26.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.64B |
| Shareholders Equity (Quarterly) | 26.74B |
| Debt to Equity Ratio | 0.5957 |
| Current Ratio | 0.7761 |
| Net Debt Paydown Yield | -0.63% |